|
|
|
|
*600727
|
|
NUCLEAR FACTOR I/A; NFIA
|
|
| Alternative titles; symbols |
TRANSCRIPTION FACTOR NFIA
KIAA1439 |
|
| HGNC Approved Gene Symbol: NFIA |
|
|
Cytogenetic location: 1p31.3
Genomic coordinates (GRCh37): 1:61,542,945-61,928,459 (from NCBI)
|
|
| TEXT |
|
Description
|
Nuclear factor I (NFI) proteins, such as NFIA, constitute a family of dimeric DNA-binding proteins with similar, and possibly identical, DNA-binding specificity. They function as cellular transcription factors and as replication factors for adenovirus DNA replication. Diversity in this protein family is generated by multiple genes, differential splicing, and heterodimerization (summary by Qian et al., 1995).  |
|
|
Cloning and Expression
|
Qian et al. (1995) isolated partial cDNA sequences derived from 4 independent genes: NFIA, NFIB (600728), NFIC (600729), and NFIX (164005). 
By sequencing clones obtained from an adult brain cDNA library, Nagase et al. (2000) cloned NFIA, which they designated KIAA1439. The deduced protein contains 561 amino acids and shares complete sequence identity with rat nuclear factor-1 over 509 amino acids. RT-PCR ELISA detected moderate to high expression in all tissues examined. Highest expression was detected in heart and liver, followed by brain, lung, ovary, skeletal muscle, kidney, testis, fetal liver, fetal brain, pancreas, and spleen. NFIA was expressed at moderate to high levels in all adult brain regions tested, with highest expression in cerebellum and caudate nucleus.  |
|
|
Gene Structure
|
Grunder et al. (2003) determined that the NFIA gene contains 11 exons. By ortholog comparisons using protein sequences from 7 vertebrate species, they identified 12 NFIA variants that are produced by alternative splicing.  |
|
|
Mapping
|
By FISH, Qian et al. (1995) mapped the NFIA and NFIB genes to chromosomes 1p31.3-p31.2 and 9p24.1, respectively. They localized the NFIC and NFIX genes to chromosome 19p13.3 in the order cen--NFIX--NFIC--tel. Comparison of the position of NFI genes and JUN genes (see JUNB, 165161) revealed a close physical linkage between members of the NFI and JUN gene families in the human genome. 
By FISH, Grunder et al. (2003) mapped the mouse Nfia and Nfib genes to chromosome 4C4-C6.  |
|
|
Gene Function
|
Deneen et al. (2006) found that Nfia and Nfib were induced in the spinal cord ventricular zone of mouse embryos concomitant with induction of Glast (SLC1A3; 600111), a marker of gliogenesis. Using mouse and chicken embryos and embryonic rat cortical progenitor cells, they showed that Nfia and Nfib were necessary and sufficient to promote glial cell fate specification. At later embryonic stages, Nfia and Nfib promoted terminal astrocyte differentiation. Nfia also inhibited neurogenesis in ventricular zone progenitors. 
Rosa et al. (2007) identified a pathway by which PU.1 (SPI1; 165170) Rosa et al. (2007) identified a pathway by which PU.1 (SPI1; 165170) regulated human monocyte/macrophage differentiation. PU.1 activated transcription of MIR424 (300682), which translationally repressed NFIA, resulting in activation of differentiation-specific genes, such as MCSFR (CSF1R; 164770). 
regulated human monocyte/macrophage differentiation. PU.1 activated transcription of MIR424 (300682), which translationally repressed NFIA, resulting in activation of differentiation-specific genes, such as MCSFR (CSF1R; 164770). |
|
|
Molecular Genetics
|
Lu et al. (2007) reported 5 patients, including 2 half sibs, with balanced translocations or interstitial deletions of chromosome 1q31-q32 (613735) involving the NFIA gene confirmed by FISH and Southern blot analysis. Three of the patients had been previously reported by Campbell et al. (2002) and Shanske et al. (2004). The 2 half sibs had a 12-Mb deletion involving approximately 47 additional genes, and another patient had a 12-Mb deletion of chromosome 2q encompassing 39 additional genes, as well as a translocation involving chromosome 1p. The remaining 2 patients had a translocation with a microdeletion and a translocation, respectively. All 5 showed a similar phenotype characterized by hypoplastic or absent corpus callosum, hydrocephalus or ventriculomegaly, and developmental delay. Four patients had a tethered spinal cord, 3 had Chiari type I malformation, and 3 had seizures. In addition, 3 patients had urinary tract defects, including vesicoureteral reflux and urinary incontinence. Although all 5 cases had haploinsufficiency of NFIA, each case also had involvement of 1 or more additional genes, which may have contributed to the phenotype. Intragenic mutations in the NFIA gene were not identified in any of the patients or in 219 additional patients with various neurologic developmental abnormalities. Lu et al. (2007) noted the phenotypic similarities to Nfia loss of function in the mouse and suggested that haploinsufficiency of the NFIA gene contributed to the malformation syndrome in these patients.  |
|
|
Animal Model
|
Das Neves et al. (1999) found that disruption of the mouse Nfia gene caused perinatal lethality. More than 95% of Nfia null animals died within 2 weeks after birth. Newborn animals lacked a corpus callosum and showed ventricular dilation indicating early hydrocephalus. Rare surviving homozygous mice lacked a corpus callosum, showed severe communicating hydrocephalus, a full-axial tremor indicative of neurologic defects, male sterility, and low female fertility, but they had near normal life spans.  |
|
| REFERENCES |
| 1. |
Campbell, C. G. N., Wang, H., Hunter, G. W.
Interstitial microdeletion of chromosome 1p in two siblings.
Am. J. Med. Genet. 111: 289-294, 2002.
[PubMed: 12210325, related citations]
[Full Text]
|
|
| 2. |
das Neves, L., Duchala, C. S., Godinho, F., Haxhiu, M. A., Colmenares, C., Macklin, W. B., Campbell, C. E., Butz, K. G., Gronostajski, R. M.
Disruption of the murine nuclear factor I-A gene (Nfia) results in perinatal lethality, hydrocephalus, and agenesis of the corpus callosum.
Proc. Nat. Acad. Sci. 96: 11946-11951, 1999. Note: Erratum: Proc. Nat. Acad. Sci. 98: 4276 only, 2001.
[PubMed: 10518556, images, related citations]
[Full Text]
|
|
| 3. |
Deneen, B., Ho, R., Lukaszewicz, A., Hochstim, C. J., Gronostajski, R. M., Anderson, D. J.
The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord.
Neuron 52: 953-968, 2006.
[PubMed: 17178400, related citations]
[Full Text]
|
|
| 4. |
Grunder, A., Qian, F., Ebel, T. T., Mincheva, A., Lichter, P., Kruse, U., Sippel, A. E.
Genomic organization, splice products and mouse chromosomal localization of genes for transcription factor Nuclear Factor One.
Gene 304: 171-181, 2003.
[PubMed: 12568726, related citations]
[Full Text]
|
|
| 5. |
Lu, W., Quintero-Rivera, F., Fan, Y., Alkuraya, F. S., Donovan, D. J., Xi, Q., Turbe-Doan, A., Li, Q.-G., Campbell, C. G., Shanske, A. L., Sherr, E. H., Ahmad, A., and 16 others.
NFIA haploinsufficiency is associated with a CNS malformation syndrome and urinary tract defects.
PLoS Genet. 3: e80, 2007. Note: Electronic Article.
[PubMed: 17530927, images, related citations]
[Full Text]
|
|
| 6. |
Nagase, T., Kikuno, R., Ishikawa, K., Hirosawa, M., Ohara, O.
Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.
DNA Res. 7: 65-73, 2000.
[PubMed: 10718198, related citations]
[Full Text]
|
|
| 7. |
Qian, F., Kruse, U., Lichter, P., Sippel, A. E.
Chromosomal localization of the four genes (NFIA, B, C, and X) for the human transcription factor nuclear factor I by FISH.
Genomics 28: 66-73, 1995.
[PubMed: 7590749, related citations]
[Full Text]
|
|
| 8. |
Rosa, A., Ballarino, M., Sorrentino, A., Sthandier, O., De Angelis, F. G., Marchioni, M., Masella, B., Guarini, A., Fatica, A., Peschle, C., Bozzoni, I.
The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation.
Proc. Nat. Acad. Sci. 104: 19849-19854, 2007.
[PubMed: 18056638, images, related citations]
[Full Text]
|
|
| 9. |
Shanske, A. L., Edelmann, L., Kardon, N. B., Gosset, P., Levy, B.
Detection of an interstitial deletion of 2q21-22 by high resolution comparative genomic hybridization in a child with multiple congenital anomalies and an apparent balanced translocation.
Am. J. Med. Genet. 131A: 29-35, 2004.
[PubMed: 15368480, related citations]
[Full Text]
|
|
|
|
| ▸ Contributors: |
Patricia A. Hartz - updated : 2/4/2011 |
|
Paul J. Converse - updated : 2/7/2008 Cassandra L. Kniffin - updated : 7/10/2007 Patricia A. Hartz - updated : 4/1/2003 |
| Creation Date: |
Victor A. McKusick : 8/17/1995 |
| ▸ Edit History: |
mgross : 02/08/2011 |
|
ckniffin : 2/8/2011 terry : 2/4/2011 terry : 1/20/2010 mgross : 2/7/2008 wwang : 7/16/2007 ckniffin : 7/10/2007 mgross : 4/3/2003 terry : 4/1/2003 mark : 8/17/1995 |
|
|
|
|
|